PATENT CLAIM ANALYSIS

Application Number: 16023102
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "451000"]

Abstract:
The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide and solvates, crystalline forms and amorphous forms thereof, to the use of said compositions as a medicament; and to processes for the preparation of said compositions.

Claim (Index 55):
A process for the preparation of a pharmaceutical composition according to  claim 39  comprising the steps of:\n (a) Mixing and melting the components of the carrier matrix; \n (b) Mixing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide into the carrier matrix in order to obtain a homogenous mixture; and \n (c) Filling the product of step (b) into a capsule and allowing the mixture to cool to form a viscous liquid, semi-solid or solid mass within the capsule.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 94.0
- Lexical Diversity: 1.37838
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13463499', '14698151', '13391440', '14197476', '13414369']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7219237432691794
- 35 USC 102 Novelty (BERT): 0.4922304963549257
- Combined Prediction Score: 0.6989544185777541
- Mean Citation Score: 219.52810600000004
- Max Citation Score: 251.7257
- Similarity Product: 201.66188839322925

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test